CA Stock MarketDetailed Quotes
MDNA Medicenna Therapeutics Corp
- 1.830
- 0.0000.00%
15min DelayMarket Closed Jun 19 16:00 ET
136.85MMarket Cap-7956P/E (TTM)
1.900High1.810Low25.74KVolume1.870Open1.830Pre Close47.47KTurnover2.98052wk High0.05%Turnover Ratio74.78MShares0.21552wk Low-0.23EPS TTM88.00MFloat Cap7.250Historical HighLossP/E (Static)48.09MShs Float0.215Historical Low-0.16EPS LYR4.92%Amplitude--Dividend TTM7.35P/B1Lot Size--Div YieldTTM
Medicenna Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -10.09%-4.03M | 10.95%-3.92M | -50.39%-3.47M | 46.33%-12.66M | 20.92%-2.29M | 46.05%-3.66M | 52.84%-4.4M | 49.56%-2.31M | -54.03%-23.58M | -34.12%-2.9M |
| Net income from continuing operations | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M | 89.04%-896K | 34.94%-4.16M | -30.59%-22.58M | 44.86%-3.21M |
| Operating gains losses | 102.12%73K | 68.14%-960K | -646.43%-1.25M | -4,578.51%-5.42M | --1.2M | ---3.44M | -4,266.67%-3.01M | -188.42%-168K | -54.68%121K | --0 |
| Depreciation and amortization | 0.00%1K | -50.00%1K | --1K | -89.47%4K | -87.50%1K | -90.00%1K | -80.00%2K | --0 | -5.00%38K | -27.27%8K |
| Remuneration paid in stock | -53.24%159K | -37.91%267K | -27.27%296K | -3.11%1.37M | -15.28%194K | -20.00%340K | 5.65%430K | 14.97%407K | 40.66%1.42M | -11.58%229K |
| Other non cashItems | ---- | ---- | -163.64%-29K | -32.29%-975K | -22.38%-853K | -170.00%-27K | -112.65%-84K | 98.41%-11K | -4,813.33%-737K | -13,840.00%-697K |
| Change In working capital | 18.09%718K | 155.23%465K | -76.56%380K | 230.69%2.41M | 33.03%1.02M | 125.38%608K | 61.22%-842K | -17.04%1.62M | -371.18%-1.84M | -75.14%769K |
| -Change in receivables | -1.80%546K | 90.50%-155K | -54.80%947K | 414.03%1.23M | -56.38%212K | -18.11%556K | 38.39%-1.63M | 91.85%2.1M | 75.68%-392K | -59.36%486K |
| -Change in payables and accrued expense | 230.77%172K | -21.52%620K | -19.62%-567K | 181.20%1.18M | 186.57%811K | 101.69%52K | 65.27%790K | -154.99%-474K | -163.35%-1.45M | -85.08%283K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -10.09%-4.03M | 10.95%-3.92M | -50.39%-3.47M | 46.33%-12.66M | 20.92%-2.29M | 46.05%-3.66M | 52.84%-4.4M | 49.56%-2.31M | -54.03%-23.58M | -34.12%-2.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 100.48%10.05M | 0 | |||||||
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 100.48%10.05M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 100.48%10.05M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 538.47%24.76M | -322.35%-189K | -96.09%136K | 38,988.52%23.84M | 277.04%969K | -78.76%3.88M | -99.11%85K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 5.13%-37K | -33.33%-16K |
| Net common stock issuance | --0 | --0 | --0 | 605.61%24.76M | --0 | -101.56%-53K | --23.84M | --969K | -69.25%3.51M | -98.46%101K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---189K | ---- | ---- | ---- | -94.10%406K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | 538.47%24.76M | -322.35%-189K | -96.09%136K | 38,988.52%23.84M | 277.04%969K | -78.76%3.88M | -99.11%85K |
| Net cash flow | ||||||||||
| Beginning cash position | -35.80%25.69M | 53.42%29.62M | 63.60%33.6M | -32.40%20.54M | 54.55%36.15M | 139.73%40.01M | -25.49%19.3M | -32.40%20.54M | 33.82%30.38M | 0.66%23.39M |
| Current changes in cash | -14.34%-4.03M | -120.17%-3.92M | -159.39%-3.47M | 225.34%12.1M | 11.81%-2.48M | -152.50%-3.52M | 309.58%19.44M | 68.73%-1.34M | -221.34%-9.66M | -137.83%-2.81M |
| Effect of exchange rate changes | 128.96%97K | -100.55%-7K | -588.57%-513K | 620.65%958K | -71.11%-77K | -8,275.00%-335K | 2,081.03%1.27M | 154.40%105K | 34.52%-184K | 84.85%-45K |
| End cash Position | -39.82%21.76M | -35.80%25.69M | 53.42%29.62M | 63.60%33.6M | 63.60%33.6M | 54.55%36.15M | 139.73%40.01M | -25.49%19.3M | -32.40%20.54M | -32.40%20.54M |
| Free cash from | -10.09%-4.03M | 10.95%-3.92M | -50.39%-3.47M | 46.33%-12.66M | 20.92%-2.29M | 46.05%-3.66M | 52.84%-4.4M | 49.56%-2.31M | -54.03%-23.58M | -34.12%-2.9M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg